Jupiter Neurosciences, Inc. (JUNS) Balance Sheet

NASDAQ: JUNSAssets, liabilities, debt and equity over 7 years.

JUNS balance sheet, 2025

December 31, 2025 · U.S. dollars

$5.6M assets = $7.4M liabilities + −$1.8M equity

What it owns$5.6MCash & ST investments: $3.8M (68.1%)Cash & ST investments$3.8M · 68%Receivables: $2,637 (0.0%)Inventory: $159,790 (2.9%)Other current: $873,209 (15.7%)Other current$873,209 · 16%PP&E: $23,214 (0.4%)Other non-current: $715,838 (12.9%)Other non-current $715,838=How it is financed$7.4MCurrent liabilities: $7.4M (100.0%)Current liabilities$7.4M · 100%

Liabilities exceed assets: shareholders’ equity is negative (−$1.8M).

Both columns are drawn to the same scale: what JUNS owns equals what it owes plus shareholders’ equity. Hover a block for its value.

JUNS financial health

Current ratio0.65
Tight · current assets cover current liabilities 0.65×
Equity / assets−32.9%
Thin equity · of assets funded by shareholders
Cash / debt71.2%
Partial cover · cash & short-term investments vs total debt
Goodwill & intangibles0.0%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

JUNS balance sheet trends, 2019–2025

Jupiter Neurosciences, Inc. balance sheet trends
MetricTrendThenLatestChange
Total assets$6,1772019$5.6M2025+210.8%/yr
Total liabilities$5.0M2019$7.4M2025+6.7%/yr
Shareholders’ equity−$5.0M2019−$1.8M2025—
Cash & short-term investments$1,2762019$3.8M2025+279.1%/yr
Total debt$1.2M2019$5.3M2025+28.0%/yr
Net cash (debt)−$1.2M2019−$1.5M2025−$322,270
Working capital−$5.0M2019−$2.6M2025+$2.4M
Book value per share−$16.302022−$3.972025—
Current ratio0.0020190.652025+0.65
Shares outstanding438K2022462K2025+1.7%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

JUNS assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

JUNS liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

JUNS debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

JUNS balance sheet

Jupiter Neurosciences, Inc. annual balance sheet
2025202420232022202120202019
Assets
Cash & short-term investments$3.8M$3.8M$28,478$64,431$330,602$207,998$1,276
Cash & equivalents$3.8M$3.8M$28,478$64,431$330,602$207,998$1,276
Receivables$2,637$0$0$0$0$126,233$0
Inventory$159,790$0$0$0$0$0$0
Other current assets$873,209$880,753$261$5,232$124,072$215,752$3,692
Total current assets$4.8M$4.7M$28,739$69,663$454,674$549,983$4,968
Property, plant & equipment (net)$23,214$69,642$116,070$162,498$208,926$0$0
Goodwill & intangible assets$0$0$0$0$0$0$0
Long-term investments$0$0$0$0$0$0$0
Other non-current assets$715,838$1.5M$3,783$3,783$3,783$0$1,209
Total assets$5.6M$6.2M$148,592$235,944$667,383$549,983$6,177
Liabilities
Accounts payable$131,130$278,676$189,495$187,032$256,893$252,192$131,051
Short-term debt$5.3M$196,514$2.1M$1.8M$486,800$108,479$1.2M
Deferred revenue$735——————
Total current liabilities$7.4M$2.0M$5.8M$7.3M$5.7M$4.3M$5.0M
Long-term debt$0$0$106,712$0$0$0$0
Lease obligations$21,247$71,329$119,542$165,945$210,591$0—
Other long-term liabilities$0$21,247$71,327$119,544$164,401$0$0
Total liabilities$7.4M$2.0M$5.9M$7.4M$5.8M$4.3M$5.0M
Shareholders' equity
Common stock & paid-in capital$3,444$3,310$2,654$2,637$653$627$553
Retained earnings (deficit)−$34.7M−$26.0M−$23.6M−$18.8M−$13.8M−$9.6M−$8.0M
Total shareholders' equity−$1.8M$4.2M−$5.8M−$7.1M−$5.2M−$3.7M−$5.0M
Key figures
Total debt$5.3M$217,761$2.2M$1.9M$651,201$108,479$1.2M
Net cash (debt)−$1.5M$3.6M−$2.2M−$1.8M−$320,599$99,519−$1.2M
Working capital−$2.6M$2.6M−$5.7M−$7.2M−$5.2M−$3.7M−$5.0M
Tangible book value−$1.8M$4.2M−$5.8M−$7.1M−$5.2M−$3.7M−$5.0M
Book value per share−$3.97$10.87−$13.23−$16.30———
Shares outstanding462K384K438K438K———
Current ratio0.652.310.000.010.080.130.00
Quick ratio0.511.880.000.010.060.080.00
Debt / equity—0.05—————
Equity / assets−32.9%67.3%−3,904.2%−3,027.9%−775.8%−674.7%−81,205.4%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed April 1, 2026); data from EODHD.

JUNS financial position

At the end of fiscal 2025 (December 31, 2025), Jupiter Neurosciences had total assets of $5.6 million (down 10.3% from a year earlier), total liabilities of $7.4 million and shareholders' equity of -$1.8 million. It held $3.8 million in cash and short-term investments against $5.3 million of debt, net debt of $1.5 million. Its current ratio was 0.65. In the latest quarter (ended June 30, 2026) total assets were $3.7 million and equity -$0.4 million.

Related: JUNS income statement, JUNS cash flow statement, JUNS key metrics. See the JUNS stock overview for the latest quote and news.

JUNS balance sheet FAQ

What are Jupiter Neurosciences's total assets?

Jupiter Neurosciences reported total assets of $5.6 million at the end of fiscal 2025 (December 31, 2025), compared with $6.2 million a year earlier.

How much debt does Jupiter Neurosciences have?

Jupiter Neurosciences had $5.3 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was —.

How much cash does Jupiter Neurosciences have?

Jupiter Neurosciences held $3.8 million in cash and short-term investments at the end of fiscal 2025; with $5.3 million of debt that is net debt of $1.5 million.

What is Jupiter Neurosciences's book value?

Jupiter Neurosciences's shareholders' equity (book value) was -$1.8 million at the end of fiscal 2025, or −$3.97 per share.

What is Jupiter Neurosciences's current ratio?

Jupiter Neurosciences had current assets of $4.8 million and current liabilities of $7.4 million, a current ratio of 0.65 (current liabilities exceed current assets).

Biotechnology: balance sheet